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Purpose/Objective: Deep inhalation breath-hold (DIBH) for 
postoperative, left-sided, breast irradiation is known to be an 
effective technique for reducing the dose to the heart. Respiratory 
phase reproducibility of DIBH and planning dose reduction were 
investigated. 
Materials and Methods: DIBH was applied to 17 patients for 
postoperative, left-sided, whole breast tangential radiotherapy with 
50 Gy in 25 fractions after breast-conserving surgery between 
February and August 2012. Respiratory phase reproducibility was 
assessed by measuring multiple clip position three times on the 
surface of lesion of planning CT images under DIBH. Immediately 
before first fraction delivery, an electric portal imaging device (EPID) 
was used to register the breast position with digitally reconstructed 
radiography (DRR). During the rest of the fractional deliveries, setup 
errors were recorded by calculating EPID image isocenter differences 
between the day and the first day. During dose delivery, EPID cine 
mode was used to continuously monitor the breast position. Doses 
delivered to the left anterior descending coronary artery (LAD) were 
evaluated on the planning CT, and D5, mean dose, V5, and V40 in the 
heart were calculated. 
Results: The standard deviation of the measured clip positions from 
the three planning CT images under DIBH were 0.40 mm in the lateral 
direction (RL), 0.85 mm in the anteroposterior direction (AP), 1.12 
mm in the craniocaudal direction (CC), Fig.1 shows the scatter gram 
of the clip positions for the 17 patients. The measured EPID isocenter 
shift from the initial EPID verified by DRR image was 2.41±1.64 mm 
(standard deviation) in CC and 1.93±1.64 mm in AP for the 17 
patients. A random error was calculated as a root mean square of the 
standard deviation for each patient over the 17 patients: 1.72 mm in 
CC and 1.27 mm in AP. A systematic error was given by a standard 
deviation of mean isocenter shift for each patient over the 17 
patients: 1.04 mm in CC and 0.92 mm in AP. The LAD D5, mean dose, 
V5, and V40 were 10.76±7.73 Gy, 4.41±1.6 Gy, 19.63%±15.19%, and 
0.034%±0.058%, respectively, under DIBH. In simulation planning using 
breath-free CT, LAD D5, mean dose, V5, and V40 were 36.36±12.11 
Gy, 13.42±5.5 Gy, 48.31%±8.37%, and 10.85%±12.25%, respectively. 
DIBH significantly reduced the dose to the LAD compared with free-
breathing CT. 
 Fig.1 
 
Conclusions: It was confirmed that DIBH provided good respiratory 
reproducibility, and the dose to the LAD was insignificant. DIBH 
significantly reduced the dose to the LAD.  
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Purpose/Objective: New technology improvements allow to deliver 
large fields and extremely modulated treatments as total marrow 
irradiation (TMI) or total lymphoid irradiation (TLI) for a specific 
subset of onco-hematological patients. These complex treatments 
need a precise, comfortable and reproducible patient’s positioning. 
We investigate the feasibility of set-up and dose delivery verification 
for patients who underwent to TMI and TLI with Helical Tomotherapy 
(HT). 
Materials and Methods: Between March 2009 and April 2012, forty-
five patients underwent to TMI (35) and TLI (10). The Clinical Target 
Volume (CTV) covered all the major lymphatic stations, from the neck 
to the inguinal region and whole body bones respectively for TLI and 
TMI. A 4 mm CTV expansion defined the Planning Target Volume 
(PTV). Set-up was performed with patients in supine position with 3 
thermoplastic masks for head, thorax and feet.Three Mega Voltage CT 
(MVCT) defined the right position for the upper, middle and lower 
part of the target before every treatment delivery. To measure the in-
vivo radiation dose distribution, GafChromic® films and MOSFET 
dosimeters were placed on the sternum and abdomen for TMI and on 
the skin of axilla, inguinal and parotid region for TLI. 
Results: The means of the corrections for rotational, longitudinal, 
lateral shifts respectively for head, thorax and pelvis define the set-
up of patients.The shift range never exceeded the PTV margins and 
the most frequent reported set-up error corrections were lower than 2 
mm. The measured point dose of two different kind of dosimeter was 
compared with the adapted dose recalculated with HT adaptive 
software. The differences between dose planned with adaptation and 
measured in-vivo were under 20%. The patients’ compliance was good 
and ameliorated with an open mask for the head. 
 
 
Conclusions: Set-up of patients for TMI/TLI HT treatments is feasible 
and reproducible. Patients can tolerate well long treatment time 
delivery. Adaptive software should be a good alternative of in-vivo 
dosimetry.  
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Purpose/Objective: The purpose of this study is to investigate the 
differences in set up accuracy in terms of shrinkage effect and 
reproducibility between the thermoplastic casts from two 
manufacturers: Orfit and CIVCO, in the head region. 
